Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
Опубликовано: 26-11-1997
Автор(ы): Jaroslav Stanek, Jörg Frei
Принадлежит: Ciba Geigy AG, NOVARTIS AG, Novartis Erfindungen Verwaltungs GmbH
Реферат: Described are compounds of formula (I), wherein R1 is hydrogen or hydroxy; R2, R2' and R2' are each independently of the others hydrogen or a substituent other than hydrogen; either R3 is hydrogen or a substituent other than hydrogen and R4 is hydrogen or lower alkyl, or R3 and R4 together form a divalent radical of the formula -(CH2)n- wherein n is 2 or 3; R5 and R6 are each indenpendently of the other hydrogen, alkyl or aryl; and either R7 and R8 are each hydrogen, or R7 and R8 together form a bond; tautomers thereof, provided that at least one tautomerisable group is present; and salts thereof. The compounds inhibit the enzyme S-adenosylmethionine decarboxylase and are suitable, for example, for the treatment of tumors and protozoal infections.
Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
Номер патента: CA2210533C. Автор: Jörg Frei,Jaroslav Stanek. Владелец: NOVARTIS AG. Дата публикации: 2007-12-04.